FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1816590717> ?p ?o ?g. }

• W1816590717 endingPage "6862" @default.
• W1816590717 startingPage "6850" @default.
• W1816590717 abstract "ICP0 is a nuclear phosphoprotein involved in the activation of herpes simplex virus type 1 (HSV-1) gene expression during lytic infection and reactivation from viral latency. Although available evidence suggests that ICP0 acts at the level of transcription, definitive studies specifically addressing this issue have not been reported. In the present study we measured the ability of ICP0 to activate gene expression (i) from promoters representing the major kinetic classes of viral genes in transient expression assays and (ii) from the same promoters during viral infection at multiplicities of infection ranging from 0.1 to 5.0 PFU/cell. The levels of synthesis and steady-state accumulation of mRNA, mRNA stability, and levels of protein synthesis were compared in cells transfected with a reporter plasmid in the presence and absence of ICP0 and in cells infected with wild-type HSV-1 or an ICP0 null mutant, n212. In transient expression assays and during viral infection at all multiplicities tested, the levels of steady-state mRNA and protein were significantly lower in the absence of ICP0, indicating that ICP0 activates gene expression at the level of mRNA accumulation. In transient expression assays and during infection at low multiplicities (< 1 PFU/cell) in the presence or absence of ICP0, marked increases in the levels of viral mRNAs accompanied by proportional increases in the levels of protein synthesis were observed with increasing multiplicity. At a high multiplicity (5 PFU/cell) in the presence or absence of ICP0, mRNA levels did not increase as a function of multiplicity and changes in the levels of protein were no longer related to changes in the levels of mRNA. Collectively, these tests indicate that transcription of viral genes is rate limiting at low multiplicities and that translation is rate limiting at high multiplicities, independent of ICP0. Consistent with the lower levels of mRNA detected in the absence of ICP0, the rates of transcription initiation measured by nuclear run-on assays were uniformly lower in cells infected with the ICP0 null mutant at all multiplicities tested, implying that ICP0 enhances transcription at or before initiation or both. No evidence was found of posttranscriptional effects of ICP0 (i.e., effects on the stability of mRNA, nuclear-cytoplasmic distribution, polyribosomal mRNA distribution, or rates of protein synthesis). Taken together, these results suggest that ICP0 activates gene expression prior to or at the level of initiation of mRNA synthesis in transient expression assays and during viral infection. Based on these findings; we hypothesize that the exaggerated multiplicity-dependent growth phenotype characteristic of ICP0 null mutants reflects the requirement for ICP0 under conditions where the steady-state level of mRNA is rate limiting, such as during low-multiplicity infection and reactivation from latency." @default.
• W1816590717 created "2016-06-24" @default.
• W1816590717 creator A5011600825 @default.
• W1816590717 creator A5039113255 @default.
• W1816590717 date "1997-09-01" @default.
• W1816590717 modified "2023-10-17" @default.
• W1816590717 title "Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis" @default.
• W1816590717 cites W1033914640 @default.
• W1816590717 cites W123433535 @default.
• W1816590717 cites W1490731141 @default.
• W1816590717 cites W1507006450 @default.
• W1816590717 cites W1508231388 @default.
• W1816590717 cites W1516008369 @default.
• W1816590717 cites W1516191360 @default.
• W1816590717 cites W1526130707 @default.
• W1816590717 cites W1546066420 @default.
• W1816590717 cites W1559441251 @default.
• W1816590717 cites W1567025402 @default.
• W1816590717 cites W1583466448 @default.
• W1816590717 cites W1587078234 @default.
• W1816590717 cites W1592452078 @default.
• W1816590717 cites W1656209509 @default.
• W1816590717 cites W1704636106 @default.
• W1816590717 cites W1733825645 @default.
• W1816590717 cites W1737368378 @default.
• W1816590717 cites W1747817694 @default.
• W1816590717 cites W1755293693 @default.
• W1816590717 cites W1763401036 @default.
• W1816590717 cites W1817074176 @default.
• W1816590717 cites W1824684517 @default.
• W1816590717 cites W1895304651 @default.
• W1816590717 cites W1900646268 @default.
• W1816590717 cites W1931233319 @default.
• W1816590717 cites W1931385722 @default.
• W1816590717 cites W1934442554 @default.
• W1816590717 cites W1954109446 @default.
• W1816590717 cites W1956073586 @default.
• W1816590717 cites W1963554219 @default.
• W1816590717 cites W1965372133 @default.
• W1816590717 cites W1966063731 @default.
• W1816590717 cites W1975647987 @default.
• W1816590717 cites W1975981148 @default.
• W1816590717 cites W1983547790 @default.
• W1816590717 cites W1984081479 @default.
• W1816590717 cites W2003638865 @default.
• W1816590717 cites W2008494281 @default.
• W1816590717 cites W2013607556 @default.
• W1816590717 cites W2020044404 @default.
• W1816590717 cites W2024810195 @default.
• W1816590717 cites W2048167369 @default.
• W1816590717 cites W2059823369 @default.
• W1816590717 cites W2069957099 @default.
• W1816590717 cites W2072229797 @default.
• W1816590717 cites W2075007419 @default.
• W1816590717 cites W2079572279 @default.
• W1816590717 cites W2081710371 @default.
• W1816590717 cites W2095142181 @default.
• W1816590717 cites W2099831088 @default.
• W1816590717 cites W2103061497 @default.
• W1816590717 cites W2103552572 @default.
• W1816590717 cites W2110800562 @default.
• W1816590717 cites W2116949284 @default.
• W1816590717 cites W2118300475 @default.
• W1816590717 cites W2127217324 @default.
• W1816590717 cites W2129129906 @default.
• W1816590717 cites W2139086665 @default.
• W1816590717 cites W2145197623 @default.
• W1816590717 cites W2146870828 @default.
• W1816590717 cites W2147990979 @default.
• W1816590717 cites W2149606427 @default.
• W1816590717 cites W2154947167 @default.
• W1816590717 cites W2155343592 @default.
• W1816590717 cites W2166195788 @default.
• W1816590717 cites W2166399014 @default.
• W1816590717 cites W2167414261 @default.
• W1816590717 cites W2171204713 @default.
• W1816590717 cites W2171553929 @default.
• W1816590717 cites W2178678932 @default.
• W1816590717 cites W26198858 @default.
• W1816590717 doi "https://doi.org/10.1128/jvi.71.9.6850-6862.1997" @default.
• W1816590717 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/191966" @default.
• W1816590717 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9261410" @default.
• W1816590717 hasPublicationYear "1997" @default.
• W1816590717 type Work @default.
• W1816590717 sameAs 1816590717 @default.
• W1816590717 citedByCount "83" @default.
• W1816590717 countsByYear W18165907172013 @default.
• W1816590717 countsByYear W18165907172014 @default.
• W1816590717 countsByYear W18165907172015 @default.
• W1816590717 countsByYear W18165907172016 @default.
• W1816590717 crossrefType "journal-article" @default.
• W1816590717 hasAuthorship W1816590717A5011600825 @default.
• W1816590717 hasAuthorship W1816590717A5039113255 @default.
• W1816590717 hasBestOaLocation W18165907171 @default.
• W1816590717 hasConcept C101762097 @default.
• W1816590717 hasConcept C104317684 @default.
• W1816590717 hasConcept C105580179 @default.
• W1816590717 hasConcept C150194340 @default.

• next